Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Miriplatin is a lipophilic derivative of cisplatin (Item No. 13119) containing myristic acid (Item No. 13351).1 It decreases growth but increases serum levels of aspartate aminotransferase (AST) and alanine transaminase (ALT) in an AH109A-TC rat orthotopic hepatocellular carcinoma model when administered intra-arterially. Formulations containing miriplatin have been used in the treatment of hepatocellular carcinoma.
WARNING This product is not for human or veterinary use.
1. Antitumor effects of a novel lipophilic platinum complex (SM-